Towards a Reference Architecture for Female-Sensitive Drug Management
2021
- 140Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage140
- Downloads114
- Abstract Views26
Artifact Description
Due to various biological factors, males and females differ in their response to drug treatment. However, there is still a lack of knowledge of the effects resulting from sex-differences in the medical field, especially due to the issue of underrepresentation of females in clinical studies. Considering severe diseases that are related to the cardiovascular system, which are likely to be perilous, counteracting this lack and emphasizing the need for sex-dependent drug treatment is of high importance. Thus, this research-in-progress paper aims at strengthening the female perspective in drug management by proposing design considerations on IS regarding recommender systems in healthcare for reinforcing shared decision-making and person-centered care. The resulting artefact presented will be a reference architecture with a mobile application as the interface to patients and healthcare professionals as well as a data- driven backend to collect and process data on sex specificity in the medical treatment of cardiovascular diseases (CVD).
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know